Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-07

Clinical Trial Update: Comparative Study Between Dexmedetomidine and Fentanyl as Adjuvants to Bupivacaine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing dexmedetomidine versus fentanyl as adjuvants to bupivacaine for postoperative pain management has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • Dexmedetomidine (Dexmedetomidine)
  • FENTANYL (FENTANYL)

Snippet

Sponsor: Ain Shams University | Conditions: Post Operative Pain | Phase 4 | Status: COMPLETED